OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
102
Results
Show all
Save search
Copy query
Show results for
Unknown
(102)
Publication Date
Release Date
2022
(18)
2023
(17)
2021
(13)
2025
(11)
2024
(7)
2015
(6)
2020
(5)
2014
(5)
2013
(5)
2019
(4)
2018
(3)
2016
(3)
2012
(2)
2017
(1)
2011
(1)
2009
(1)
Previous
page
1 / 11
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
11
Next
page
Sort
by:
Relevance
Page size
10
Similarities and Differences in Alcohol & Other Drug Dependence Among Hispanic/Latino Subgroups: A Disaggregation Approach.
Not available
S-EPMC9949341
|
biostudies-literature
Cite
Aza-peptide aldehydes and ketones: synthesis and evaluation as human 20S proteasome inhibitors.
Not available
S-EPMC12536793
|
biostudies-literature
Cite
HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States.
Not available
S-EPMC2747529
|
biostudies-literature
Cite
The human minor histocompatibility antigen 1 is a RhoGAP.
Not available
S-EPMC3781157
|
biostudies-literature
Cite
Clinical Outcome Event Adjudication in a 10-Year Prospective Study of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B.
Not available
S-EPMC7782110
|
biostudies-literature
Cite
Major Histocompatibility Complex Class I Chain-Related A and B (MICA and MICB) Gene, Allele, and Haplotype Associations With Dengue Infections in Ethnic Thais.
Not available
S-EPMC7399699
|
biostudies-literature
Cite
A combined DPA1~DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer.
Not available
S-EPMC3395342
|
biostudies-literature
Cite
Positive effects of tree diversity on tropical forest restoration in a field-scale experiment.
Not available
S-EPMC10846868
|
biostudies-literature
Cite
Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation.
Not available
S-EPMC3931192
|
biostudies-literature
Cite
Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study.
Not available
S-EPMC4091579
|
biostudies-literature
Cite
Previous
page
1 / 11
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
11
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets